LYNCHBURG, Va., June 14, 2024--BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant
Key Insights BWX Technologies' estimated fair value is US$83.40 based on 2 Stage Free Cash Flow to Equity With US$89.07...
OTTAWA, Ontario, June 07, 2024--BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration